Trastuzumab + NK cells

DRUG2 trials

Sponsors

National University Hospital, Singapore, Xuzhou Medical University

Conditions

Breast CancerGastric Cancer

Phase 1

NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer

National University Hospital, SingaporeBreast Cancer, Gastric Cancer

Start: 2014-01-31End: 2018-08-31Target: 29Updated: 2016-06-22

Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer

Xuzhou Medical UniversityGastric Cancer

Start: 2017-01-31End: 2020-01-31Target: 20Updated: 2016-06-22

Related Papers

Tumor pathological and immunological changes in HER2+ metastatic breast cancer (MBC) following trastuzumab combined with expanded and activated autologous natural killer (NK) cell infusion.

Journal of Clinical Oncology2019-05-206 citations

Phase Ib/II trial of expanded and activated autologous natural killer (NK) cells with trastuzumab (Tras) in refractory HER2+ metastatic breast cancer (MBC).

Journal of Clinical Oncology2016-05-202 citations